Efficacy Comparison News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Efficacy Comparison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Efficacy Comparison Today - Breaking & Trending Today

Horizon Therapeutics plc Announces New UPLIZNA (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2022

Published: October 12, 2022

-- Presentations will feature analyses from the pivotal Phase 3 study of UPLIZNA, including the relationship between B-cell subsets and NMOSD attacks -- Horizon Therapeutics plc (Nasdaq: HZNP) today

Source: finanznachrichten.de

Related Topics:

Neuroimmunol NeuroinflammOrhan AktasBrian WeinshenkerTina VenturaHans Peter HartungRay GordonRachel VannProduct CommunicationsEuropean CommissionDrug AdministrationResearch In Multiple SclerosisEuropean Committee For TreatmentEuropean CommitteeMultiple SclerosisEfficacy ComparisonFirst Adjudicated AttackMatching Adjusted Indirect ComparisonDisease ActivityReceiving Inebilizumab TreatmentLow Affinity Igg Fc Region ReceptorGene PolymorphismsNeuromyelitis Optica Spectrum DisorderImmunosuppression TreatmentHepatitisb VirusProgressive Multifocal Leukoencephalopathy